Healthcare - Biotechnology - NASDAQ - US
$ 3.0
-4.46 %
$ 36.2 M
Market Cap
-0.73
P/E
CASH FLOW STATEMENT
-57.5 M
OPERATING CASH FLOW
-4.16 M
INVESTING CASH FLOW
65.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
HOOKIPA Pharma Inc.
| Net Income | -81.6 M |
| Depreciation & Amortization | 3.55 M |
| Capital Expenditures | -4.16 M |
| Stock-Based Compensation | 2.34 M |
| Change in Working Capital | 5.33 M |
| Others | 8.21 M |
| Free Cash Flow | -61.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (81.6) | (64.9) | (75.7) | (44.1) | (43.0) | (16.2) | (12.7) |
| Depreciation & Amortization | 3.6 | 3.6 | 4.6 | 4.2 | 1.4 | 0.6 | 0.4 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 2.3 | 5.0 | 7.6 | 8.7 | 5.6 | 0.9 | 0.8 |
| Other Operating Activities | 12.8 | 0.2 | 1.2 | 53 K | 1.7 | 7 K | 45 K |
| Change in Working Capital | 5.3 | 36.1 | (3.9) | (8.1) | (7.4) | (0.3) | (0.3) |
| Cash From Operations | (57.5) | (20.0) | (66.0) | (39.3) | (41.7) | (15.0) | (11.9) |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | (4.2) | (5.0) | (12.6) | (2.4) | (2.0) | (2.1) | (1.3) |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (4.2) | (5.0) | (12.6) | (2.4) | (2.0) | (2.1) | (1.3) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (1.8) | (2.9) | (0.4) | (1.4) | (2.3) | 0.4 | 0.7 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 18.4 | 29.4 | 0 | 32.2 | 37.3 | 12.9 | 116.3 |
| Cash From Financing Activities | 65.7 | 72.3 | (0.2) | 73.4 | 109.8 | 6.9 | 58.9 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | 4.1 | 46.5 | (76.3) | 29.6 | 65.0 | (12.8) | 48.2 |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (61.7) | (25.0) | (78.6) | (41.7) | (43.7) | (17.1) | (13.2) |